Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial

The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study assessing the efficacy and safety of a single-dose SBRT for men with localized prostate cancer. Aim of this paper is to present the phase I results of a 19  Gy single fraction urethra-sparing SBRT with real-time electromagnetic tracking.

Source: Radiotherapy and Oncology - August 16, 2019 Category: Radiology Authors: Thomas Zilli, Ciro Franzese, Marta Bottero, Niccol ò Giaj-Levra, Robert Förster, Daniel Zwahlen, Nikolaos Koutsouvelis, Aurelie Bertaut, Julie Blanc, Giuseppe Roberto D'agostino, Filippo Alongi, Matthias Guckenberger, Marta Scorsetti, Raymond Miralbell Tags: Short Communication Source Type: research